These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
898 related articles for article (PubMed ID: 27325326)
1. Dutch Tariff for the Five-Level Version of EQ-5D. M Versteegh M; M Vermeulen K; M A A Evers S; de Wit GA; Prenger R; A Stolk E Value Health; 2016 Jun; 19(4):343-52. PubMed ID: 27325326 [TBL] [Abstract][Full Text] [Related]
2. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set. Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan. Shiroiwa T; Ikeda S; Noto S; Igarashi A; Fukuda T; Saito S; Shimozuma K Value Health; 2016; 19(5):648-54. PubMed ID: 27565282 [TBL] [Abstract][Full Text] [Related]
4. United States Valuation of EQ-5D-5L Health States Using an International Protocol. Pickard AS; Law EH; Jiang R; Pullenayegum E; Shaw JW; Xie F; Oppe M; Boye KS; Chapman RH; Gong CL; Balch A; Busschbach JJV Value Health; 2019 Aug; 22(8):931-941. PubMed ID: 31426935 [TBL] [Abstract][Full Text] [Related]
5. Peruvian Valuation of the EQ-5D-5L: A Direct Comparison of Time Trade-Off and Discrete Choice Experiments. Augustovski F; Belizán M; Gibbons L; Reyes N; Stolk E; Craig BM; Tejada RA Value Health; 2020 Jul; 23(7):880-888. PubMed ID: 32762989 [TBL] [Abstract][Full Text] [Related]
6. Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values? Mulhern B; Shah K; Janssen MF; Longworth L; Ibbotson R Value Health; 2016; 19(2):210-7. PubMed ID: 27021755 [TBL] [Abstract][Full Text] [Related]
7. Valuation of EQ-5D-5L in the Kingdom of Saudi Arabia: A National Representative Study. Al-Jedai A; Almudaiheem H; Al-Salamah T; Aldosari M; Almutairi AR; Almogbel Y; AlRuthia Y; Althemery AU; Alluhidan M; Roudijk B; Purba FD; Awad N; O'jeil R Value Health; 2024 May; 27(5):552-561. PubMed ID: 38342365 [TBL] [Abstract][Full Text] [Related]
8. Preparatory study for the revaluation of the EQ-5D tariff: methodology report. Mulhern B; Bansback N; Brazier J; Buckingham K; Cairns J; Devlin N; Dolan P; Hole AR; Kavetsos G; Longworth L; Rowen D; Tsuchiya A Health Technol Assess; 2014 Feb; 18(12):vii-xxvi, 1-191. PubMed ID: 24568945 [TBL] [Abstract][Full Text] [Related]
9. The EQ-5D-5L Valuation study in Thailand. Pattanaphesaj J; Thavorncharoensap M; Ramos-Goñi JM; Tongsiri S; Ingsrisawang L; Teerawattananon Y Expert Rev Pharmacoecon Outcomes Res; 2018 Oct; 18(5):551-558. PubMed ID: 29958008 [TBL] [Abstract][Full Text] [Related]
10. Valuation of the EQ-5D-5L with composite time trade-off for the German population - an exploratory study. Ludwig K; von der Schulenburg JG; Greiner W Health Qual Life Outcomes; 2017 Feb; 15(1):39. PubMed ID: 28219389 [TBL] [Abstract][Full Text] [Related]
11. The EQ-5D-5L valuation study in Korea. Kim SH; Ahn J; Ock M; Shin S; Park J; Luo N; Jo MW Qual Life Res; 2016 Jul; 25(7):1845-52. PubMed ID: 26961008 [TBL] [Abstract][Full Text] [Related]
12. A national survey of Iranian general population to estimate a value set for the EQ-5D-5L. Afshari S; Daroudi R; Goudarzi R; Mahboub-Ahari A; Yaseri M; Sari AA; Ameri H; Bahariniya S; Oliaei-Manesh A; Kalavani K; Zare Z; Hasannezhad E; Mirzaei M; Amiri Z Qual Life Res; 2023 Jul; 32(7):2079-2087. PubMed ID: 36897530 [TBL] [Abstract][Full Text] [Related]
13. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets. Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577 [TBL] [Abstract][Full Text] [Related]
14. German Value Set for the EQ-5D-5L. Ludwig K; Graf von der Schulenburg JM; Greiner W Pharmacoeconomics; 2018 Jun; 36(6):663-674. PubMed ID: 29460066 [TBL] [Abstract][Full Text] [Related]
15. The EQ-5D-5L valuation study for Trinidad and Tobago. Bailey H; Jonker MF; Pullenayegum E; Rencz F; Roudijk B Health Qual Life Outcomes; 2024 Jul; 22(1):51. PubMed ID: 38956543 [TBL] [Abstract][Full Text] [Related]
16. Test-Retest Reliability of EQ-5D-5L Valuation Techniques: The Composite Time Trade-Off and Discrete Choice Experiments. Purba FD; Hunfeld JAM; Timman R; Iskandarsyah A; Fitriana TS; Sadarjoen SS; Passchier J; Busschbach JJV Value Health; 2018 Oct; 21(10):1243-1249. PubMed ID: 30314626 [TBL] [Abstract][Full Text] [Related]
17. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective. Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276 [TBL] [Abstract][Full Text] [Related]
18. A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states. Norman R; Cronin P; Viney R Appl Health Econ Health Policy; 2013 Jun; 11(3):287-98. PubMed ID: 23649892 [TBL] [Abstract][Full Text] [Related]
19. The EQ-5D-5L Valuation Study in Egypt. Al Shabasy S; Abbassi M; Finch A; Roudijk B; Baines D; Farid S Pharmacoeconomics; 2022 Apr; 40(4):433-447. PubMed ID: 34786590 [TBL] [Abstract][Full Text] [Related]
20. A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada. Xie F; Pullenayegum E; Gaebel K; Bansback N; Bryan S; Ohinmaa A; Poissant L; Johnson JA; Med Care; 2016 Jan; 54(1):98-105. PubMed ID: 26492214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]